Dr. Michael S. Saag, MD

Dr. Saag practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Dr. Saag's NPI, 1700809548, was assigned on July 25, 2006. Dr. Saag graduated from University Of Louisville School Of Medicine in 1981. Dr. Saag's Alabama license number on file is 10505.

Dr. Saag's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Dr. Saag's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dr. Saag is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Dr. Saag to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saag practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Saag's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Saag is board certified in infectious disease by the American Board of Internal Medicine. Dr. Saag has a license on file in Alabama.

Dmand AI lists acute skin infection, hiv/aids, pneumonia and respiratory infection and shingles among the conditions Dr. Saag treats.

CMS data shows 229 Medicare services from Dr. Saag across 6 procedure codes in 2024, for 106 Medicare patients. Medicare paid $13,466 for them.

CMS counts 106 Medicare patients who saw Dr. Saag in 2024. The largest group is under 65, with 46 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Saag's median patient age at 50, with 29% women.

In 2024, Dr. Saag wrote 546 Medicare Part D claims for 75 patients. 76% of them were for generic drugs. CMS names the drug for 312 of them, across 15 drugs with 11 or more claims each, at $172,018 in total drug cost. In 2023, CMS named 706 claims across 29 drugs.

Dr. Saag accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 317 papers to Dr. Saag, published from 2000 to 2025. 2016 was the busiest year, with 8. The most frequent topics are HIV Infections, Anti-HIV Agents and HIV-1. Dr. Saag has published most often in J Acquir Immune Defic Syndr. Dr. Saag's most frequent co-authors are Joseph J. Eron, MD, William Christopher Mathews, MD and Mari M. Kitahata, MD.

Dmand AI links Dr. Saag to 9 clinical trials, 2 of them phase 1/2 studies. Conditions studied include HIV Infections, Lentivirus Infections and Acquired Immunodeficiency Syndrome. National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most, 3.

CMS Open Payments shows 93 general payments to Dr. Saag from 5 drug and device companies from 2016 to 2018. Consulting fees make up the largest share, 78% of the total. Merck Sharp & Dohme Corporation paid the most, $41,245.

Dmand AI lists 3 awards for Dr. Saag, most recently America's Top Doctors in 2014.

Dr. Saag graduated from University Of Louisville School Of Medicine in 1981.

Dr. Saag is in network with 13 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.